A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum

Launched by REVISION SKINCARE · Feb 26, 2022

Keywords

ClinConnect Summary

This double-blind, randomized, controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging serum (Cell 1) to improve moderate overall photodamage and skin fatigue of aging skin after 7 days of twice-daily use when compared to the efficacy of a combination of anti-aging serum and an anti-aging facial moisturizer (Cell 2). Skin fatigue was characterized by dehydrated skin with a lack of firmness (visual) and a dull appearance on the global face.

Efficacy and tolerability were assessed through clinical grading at baseline, day 3, and day 7. Eff...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female, 30 to 60 years of age
• • Fitzpatrick skin type I -IV
• • Moderate overall photodamage of the skin
• • Moderate lack of firmness (visual) of the skin
• • Moderate dull appearance of the skin
• • Subjects must be willing to withhold all facial treatments during the course of the study and have not undergone a treatment within the last 6 months
• • Subject must be willing to provide verbal understanding and written informed consent
• Exclusion Criteria:
• • Diagnosed with known allergies to facial skincare products
• • Nursing, pregnant, or planning to become during the duration of the study
• • History of skin cancer within the past 5 years
• • Having used oral isotretinoin within the last 12 months
• • Having used prescription-strength skin-lightening products within the last 3 months
• • Having used any anti-wrinkle, skin-lightening, or other product or topical or systemic medication known to affect skin aging or dyschromia within the last 4 weeks
• • Having a health condition and/or pre-existing or dermatologic disorder that, in the Investigator's opinion, may interfere with the outcome of the study
• • Having observable sunburn, suntan, scars, excessive facial hair, or other dermal conditions on the face that, in the Investigator's opinion, may influence test results
• • Having a history of immunosuppression/immune deficiency disorders, or currently using oral or systemic immunosuppressive medications and biologics, and/or undergoing radiation or chemotherapy
• • Using or having regularly used systemic or topical corticosteroids within the past 4 weeks
• • Having started a long-term medication within the last 2 months